<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04925869</url>
  </required_header>
  <id_info>
    <org_study_id>AVC BCT</org_study_id>
    <nct_id>NCT04925869</nct_id>
  </id_info>
  <brief_title>Prospective Study of Cerebrovascular Accidents (CVA) in 3 French Cities (Besançon, Cayenne and Tours)</brief_title>
  <acronym>AVCBCT</acronym>
  <official_title>Prospective Study of Cerebrovascular Accidents (CVA) in 3 French Cities (Besançon, Cayenne and Tours)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier de Cayenne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Régional Universitaire de Tours</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Régional Universitaire, Besançon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier de Cayenne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to specify the typology of CVA in French Guiana by&#xD;
      prospectively comparing consecutive strokes observed at each of the three study sites&#xD;
      (Cayenne, Tours, Besançon)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CVA is a public health problem that is managed in a codified manner by the Neurovascular&#xD;
      Units (NU). In Cayenne, in the absence of a NU, strokes are managed directly in the emergency&#xD;
      room by 24-hour telemedicine provided by the neurovascular team at the Besançon University&#xD;
      Hospital. The vascular neurologist can perform a clinical examination remotely in a dedicated&#xD;
      examination room and has access to magnetic resonance imaging by image transfer. The Tours&#xD;
      and Besançon university hospitals each have a regional reference NU. The coordinating&#xD;
      investigator of the study is the head of the neurology department of the Tours University&#xD;
      Hospital, currently on an extended mission in Cayenne. The initial emergency management of a&#xD;
      person with stroke who is hospitalized is comparable between the three regions studied.&#xD;
&#xD;
      Epidemiological studies show disparities in stroke mortality and vascular risk factors&#xD;
      between French regions. The stroke mortality rate in French Guiana in 2013 (72 per 100 000&#xD;
      population per year) was twice that of metropolitan France. The standardized prevalence rate&#xD;
      of diabetes in French Guiana is 7.1% of the population compared with 4.4% in metropolitan&#xD;
      France, and the prevalence of hypertension is twice as high among women in the French Guiana&#xD;
      West Indies compared with metropolitan France. There are twice as many obese persons (BMI&gt;30)&#xD;
      in Guyanese women compared with metropolitan France.&#xD;
&#xD;
      We propose a prospective observational study based on the following hypothesis:&#xD;
&#xD;
      The average age of stroke occurrence, its type (ischemic or hemorrhagic), the vascular&#xD;
      territories involved, the vascular risk factors, and the pre-hospital and intra-hospital&#xD;
      management times will be superimposable between two metropolitan regions but different in&#xD;
      French Guyana.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 7, 2019</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Describe the types of CVA and assess their risk factors on clinical, radiological and biological evidence</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical assessment of stroke (NIHSS score) and systematic collection of vascular risk factors (diabetes, hypertension, dyslipidemia, emboligic heart disease) Suspected mechanism (TOAST). Modified Rankin score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the time required for treatment between Cayenne, Besançon and Tours in the event of an indication for thrombolysis</measure>
    <time_frame>3 months</time_frame>
    <description>Time to access care and management. The following will be specified: the time between the onset of symptoms and admission, MRI, and thrombolysis, if applicable.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Cerebrovascular Accident</condition>
  <condition>Thrombolysis</condition>
  <arm_group>
    <arm_group_label>The hospitals of Besançon</arm_group_label>
    <description>Adult patients with MRI-confirmed CVA admitted to the hospitals of Besançon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the hospitals of Cayenne</arm_group_label>
    <description>Adult patients with MRI-confirmed CVA admitted to the hospitals of Cayenne.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the hospitals of Tours</arm_group_label>
    <description>Adult patients with MRI-confirmed CVA admitted to the hospitals of Tours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational study</intervention_name>
    <description>Observational study</description>
    <arm_group_label>The hospitals of Besançon</arm_group_label>
    <arm_group_label>the hospitals of Cayenne</arm_group_label>
    <arm_group_label>the hospitals of Tours</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with MRI-confirmed CVA admitted to the hospitals of Besançon, Cayenne, and&#xD;
        Tours.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with a diagnosis of Cerebral Vascular Accident confirmed on MRI&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years&#xD;
&#xD;
          -  Absence of MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertrand De Toffol, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier de Cayenne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier de Cayenne</name>
      <address>
        <city>Cayenne</city>
        <state>Guiana</state>
        <zip>97306</zip>
        <country>French Guiana</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>French Guiana</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 8, 2021</study_first_submitted>
  <study_first_submitted_qc>June 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2021</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

